Intelligent Medicine Acquisition Corp. Unit
IQMDU
IQMDU was delisted on the 26th of April, 2023.
1 hedge funds and large institutions have $2.02K invested in Intelligent Medicine Acquisition Corp. Unit in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 5 closing their positions.
83% less funds holding
Funds holding: 6 → 1 (-5)
100% less capital invested
Capital invested by funds: $694K → $2.02K (-$692K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$504K |
| 2 |
CS
Clear Street
New York
|
-$179K |
| 3 |
BHWM
Beaird Harris Wealth Management
Dallas,
Texas
|
-$5.04K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.01K |
IQMDU Hedge Fund Activity: Q2 2023 in Review
1 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Unit (IQMDU) for Q2 2023, worth a combined $2.02K — down 100% from $694K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of IQMDU and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was HRT Financial, exiting entirely with an estimated $504K sold.
- 1 institutional investor held Intelligent Medicine Acquisition Corp. Unit (IQMDU) as of Q2 2023, down from 6 in Q1 2023.
- Funds reported $2.02K of Intelligent Medicine Acquisition Corp. Unit stock for Q2 2023, down 100% quarter-over-quarter.
- 0 funds opened new Intelligent Medicine Acquisition Corp. Unit positions in Q2 2023 and 5 closed out, a net change of -5 holders.
- The largest Intelligent Medicine Acquisition Corp. Unit seller in Q2 2023 was HRT Financial, an estimated $504K sold.
Based on aggregated 13F filings for Q2 2023.